Shattuck lecture--neurodegenerative diseases and prions.

Twenty-five years ago, little was known about the causes of neurodegenerative diseases. Now, however, it is clear that they result from abnormalities in the processing of proteins. In each of these diseases, defective processing causes the accumulation of one or more specific neuronal proteins. Of all the laboratory research on neurodegenerative diseases, the studies that led to the discovery of prions have yielded the most unexpected findings. The idea that a protein can act as an infectious pathogen and cause degeneration of the central nervous system was accepted only after a long and arduous battle.1 The concept of prions not . . .

[1]  D. Cleveland,et al.  Oxidation versus aggregation — how do SOD1 mutants cause ALS? , 2000, Nature Medicine.

[2]  J. Trojanowski,et al.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. , 2000, Science.

[3]  Ruedi Aebersold,et al.  Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing , 2000, Nature.

[4]  M. Balter Tracking the Human Fallout From 'Mad Cow Disease' , 2000, Science.

[5]  A. Pol Narcolepsy A Neurodegenerative Disease of the Hypocretin System? , 2000, Neuron.

[6]  Christl A. Donnelly,et al.  Predicted vCJD mortality in Great Britain , 2000, Nature.

[7]  Patrick R. Hof,et al.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.

[8]  Shinsei Minoshima,et al.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.

[9]  B. Strooper,et al.  Proteolytic processing and cell biological functions of the amyloid precursor protein. , 2000, Journal of cell science.

[10]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[11]  F. Cohen,et al.  Mimicking dominant negative inhibition of prion replication through structure-based drug design. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. Cohen,et al.  Dominant-Negative Inhibition of Prion Formation Diminished by Deletion Mutagenesis of the Prion Protein , 2000, Journal of Virology.

[13]  H. Ross,et al.  A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease , 2000, Neurology.

[14]  H. Zoghbi,et al.  Reversing Neurodegeneration:A Promise Unfolds , 2000, Cell.

[15]  W. Caughey,et al.  Porphyrin and phthalocyanine antiscrapie compounds. , 2000, Science.

[16]  P. George-Hyslop Molecular genetics of Alzheimer’s disease , 2000, Biological Psychiatry.

[17]  H. Zoghbi,et al.  Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.

[18]  S. Prusiner,et al.  Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  F. Cohen,et al.  Elimination of prions by branched polyamines and implications for therapeutics. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Zoghbi,et al.  Expanding Our Understanding of Polyglutamine Diseases through Mouse Models , 1999, Neuron.

[21]  E. Masliah,et al.  Alpha‐synuclein in Lewy Body Disease and Alzheimer's Disease , 1999, Brain pathology.

[22]  Christina A. Wilson,et al.  Intracellular APP Processing and Aβ Production in Alzheimer Disease , 1999 .

[23]  R. Motter,et al.  Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.

[24]  J. B. Martin,et al.  Molecular basis of the neurodegenerative disorders. , 1999, The New England journal of medicine.

[25]  D. Selkoe,et al.  Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.

[26]  S. Prusiner,et al.  Prion protein conformation in a patient with sporadic fatal insomnia. , 1999, The New England journal of medicine.

[27]  Sarah Tomlin,et al.  Microtechnology: Laying it on thick , 1999, Nature.

[28]  F. Cohen,et al.  Solution structure of Syrian hamster prion protein rPrP(90-231). , 1999, Biochemistry.

[29]  D. Dickson,et al.  Tau gene mutation in familial progressive subcortical gliosis , 1999, Nature Medicine.

[30]  C. Farrington,et al.  Deaths from variant Creutzfeldt-Jakob disease , 1999, The Lancet.

[31]  S. Hauser,et al.  Identification of autoantibodies associated with myelin damage in multiple sclerosis , 1999, Nature Medicine.

[32]  B. Steinhoff,et al.  diagnosis of Creutzfeldt-Jakob disease , 1998 .

[33]  H. Paulson,et al.  Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis)fold. , 1999, American journal of human genetics.

[34]  J W Langston,et al.  Parkinson disease in twins: an etiologic study. , 1999, JAMA.

[35]  S. Prusiner 2 Development of the Prion Concept , 1999 .

[36]  M. Alpers,et al.  12 Infectious and Sporadic Prion Diseases , 1999 .

[37]  S. DeArmond,et al.  14 Neuropathology of Prion Diseases , 1999 .

[38]  C. Gibbs,et al.  Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. , 1998, The New England journal of medicine.

[39]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[40]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[41]  D. Geschwind,et al.  Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Cohen,et al.  Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.

[43]  S Kobashi,et al.  Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images. , 1998, Radiology.

[44]  D. Riesner,et al.  Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy , 1998, Nature Medicine.

[45]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[47]  A. Kertesz,et al.  Pick's disease and Pick complex , 1998 .

[48]  R. Shin,et al.  Codon 219 lys allele of PRNP is not found in sporadic Creutzfeldt‐Jakob disease , 1998, Annals of neurology.

[49]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[50]  O. Gefeller,et al.  Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease , 1998, Annals of neurology.

[51]  F E Cohen,et al.  Pathologic conformations of prion proteins. , 1998, Annual review of biochemistry.

[52]  S. Prusiner,et al.  Propagation of prion strains through specific conformers of the prion protein , 1997, Journal of virology.

[53]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[54]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[55]  F. Cohen,et al.  Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Polymeropoulos,et al.  Genetics of Parkinson's disease. , 1997, Human molecular genetics.

[57]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[58]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[59]  T. Wisniewski,et al.  Alzheimer's soluble amyloid β is a normal component of human urine , 1997 .

[60]  L. Thal,et al.  Genetic evidence for the involvement of τ in progressive supranuclear palsy , 1997, Annals of neurology.

[61]  N. Hunter,et al.  Association between natural scrapie and PrP genotype in a flock of Suffolk sheep in Scotland , 1997, Veterinary Record.

[62]  S. Prusiner,et al.  Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity , 1996, Science.

[63]  R. Holman,et al.  Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases. , 1996, Emerging infectious diseases.

[64]  R. Ridley,et al.  To what extent is strain variation evidence for an independent genome in the agent of the transmissible spongiform encephalopathies? , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[65]  R. Riek,et al.  NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.

[66]  L A Beckett,et al.  Prevalence of parkinsonian signs and associated mortality in a community population of older people. , 1996, The New England journal of medicine.

[67]  Samuel M. Goldman,et al.  EPIDEMIOLOGY OF PARKINSON'S DISEASE , 1996, Neurologic Clinics.

[68]  F. Cohen,et al.  Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein , 1995, Cell.

[69]  R. Marsh,et al.  Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy , 1994, Journal of virology.

[70]  K. Wilhelmsen,et al.  Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. , 1994, American journal of human genetics.

[71]  D. Gajdusek,et al.  Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[72]  S. Prusiner Inherited prion diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[73]  S. Prusiner,et al.  Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. , 1994, Genes & development.

[74]  Claudia H. Kawas,et al.  The epidemiology of dementia and Alzheimer disease. , 1994 .

[75]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[76]  J. Ott,et al.  Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD). , 1993, American journal of human genetics.

[77]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[78]  A. Brun Frontal lobe degeneration of non-Alzheimer type revisited. , 1993, Dementia.

[79]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[80]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[81]  J. Martín,et al.  Analysis of the prion protein gene in thalamic dementia , 1992, Neurology.

[82]  C. Frith,et al.  Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. , 1992, Brain : a journal of neurology.

[83]  S. Prusiner,et al.  Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene , 1992, Nature Genetics.

[84]  S. Prusiner,et al.  Molecular biology of prion diseases , 1991, Science.

[85]  S. Prusiner,et al.  Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis , 1991, Journal of virology.

[86]  D. Wysowski,et al.  Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. , 1991, JAMA.

[87]  P. Blumbergs,et al.  Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. , 1990, Australian and New Zealand journal of medicine.

[88]  L. Thal,et al.  The Lewy body variant of Alzheimer's disease , 1990, Neurology.

[89]  M. Albert,et al.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.

[90]  P. McBride,et al.  Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie , 1989, Neuroscience Letters.

[91]  Jurg Ott,et al.  Linkage of a prion protein missense variant to Gerstmann–Sträussler syndrome , 1989, Nature.

[92]  H. Gertz,et al.  Creutzfeldt‐Jakob disease , 1988, Neurology.

[93]  S. Prusiner,et al.  Changes in the localization of brain prion proteins during scrapie infection , 1987, Neurology.

[94]  A. Dickinson,et al.  Biological evidence that scrapie agent has an independent genome. , 1987, The Journal of general virology.

[95]  M. Braunfeld,et al.  Identification of prion amyloid filaments in scrapie-infected brain , 1985, Cell.

[96]  S. Prusiner,et al.  Antibodies to a scrapie prion protein , 1984, Nature.

[97]  S. Prusiner,et al.  Some speculations about prions, amyloid, and Alzheimer's disease. , 1984, The New England journal of medicine.

[98]  C. Masters,et al.  Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. , 1981, Brain : a journal of neurology.

[99]  A. Hudson Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. , 1981, Brain : a journal of neurology.

[100]  Jonathan O. Harris,et al.  Creutzfeldt‐Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering , 1979, Annals of neurology.

[101]  D. Gajdusek,et al.  DANGER OF ACCIDENTAL PERSON-TO-PERSON TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE BY SURGERY , 1977, The Lancet.

[102]  C. Marsden,et al.  SUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASE , 1977, The Lancet.

[103]  A. Devoe,et al.  Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. , 1974, The New England journal of medicine.

[104]  M. Alter,et al.  Creutzfeldt-Jakob Disease: Focus among Libyan Jews in Israel , 1974, Science.

[105]  Bobowick Ar,et al.  Epidemiology of motor-neuron diseases. , 1973 .

[106]  D. Gajdusek,et al.  The clinical characteristics of transmissible Creutzfeldt-Jakob disease. , 1973, Brain : a journal of neurology.

[107]  W. Kirschbaum JAKOB-CREUTZFELDT DISEASE , 1968 .

[108]  H. Fraser,et al.  Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. , 1968, Journal of comparative pathology.

[109]  S. Behrman,et al.  Subacute spongiform encephalopathy--a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). , 1960, Brain : a journal of neurology.